Managers
Navicure, a provider of cloud-based claims management and patient payment solutions for physician practices and hospitals, has secured a strategic investment from Bain Capital Private Equity. Financial terms of the private transaction have not been disclosed.
Navicure, which is headquartered in Duluth, Georgia, will continue to be led by current CEO and founder, James M. Denny, Jr. and his executive team. They will retain a meaningful interest in the business. Selling shareholders include JMI Equity and other minority investors.
Navicure’s subscription-based software solutions help healthcare organisations of all sizes increase revenue, accelerate cash flow, and reduce the costs associated with
YFM Equity Partners has launched its new YFM Equity Partners 2016 Fund (YFMEP 2016), which will provide investors with the opportunity to participate in YFM’s future private equity investments which no longer qualify for VCT investment.
YFM has already secured GBP22 million from existing pension funds and new family office backers in the last three months and following this early success are now focussing on the next stage of fundraising. The team is looking to raise an additional GBP10-15m of private equity capital to be invested over YFMEP 2016’s two-year investment period. YFMEP 2016 complements YFM’s established VCT funds, increasing
Tikehau IM has acted as sole lead arranger of a EUR35 million unitranche denominated in USD for the acquisition of Cisbio Bioassays by Abénex.
Abénex acquires Cisbio Bioassays in a secondary LBO from Argos Soditic. Flexible unitranche financing denominated in US$ has been arranged by Tikehau IM.
Cisbio Bioassays is a French life sciences company committed to improving human healthcare. With more than 30 years of experience in in vitro diagnostics and drug discovery, Cisbio Bioassays provides creative technological solutions by partnering with the global scientific community in Codolet (France). Its portfolio of over 460 proprietary assays and reagents is
The Russian Direct Investment Fund (RDIF) is investing in a complex reconstruction of the federal M-4 Don highway in Russia, as part of its infrastructure partnership with Avtodor State Company.
The project involves complex installation work, reconstruction, maintenance, repair, structural repair and toll operation of the M-4 Don federal highway from Moscow through Voronezh, Rostov-on-Don, Krasnodar to Novorossiysk, at Section 4, Rostov – Krasnodar (section km 1091.6 – km 1319).
The company Road Investment Company LLC, created by RDIF and Avtodor to identify and implement road improvement projects in Russia, will act as the project operator. A number of
Dating app Once has secured a second wave of investment from Partech, the French venture capital firm, that supports global companies that they believe possess revolutionary concepts.
For this reason, Partech Ventures has just signed a second partnership deal with Once to invest a further one million euros in the dating app – signifying its confidence in the app’s successive business model.
The dating scene has become vastly populated in recent years and has been a challenging market for a new app to succeed in. Once attributes its strong continued growth in user sign ups to the fact that
Allecra Therapeutics, a biopharmaceutical company dedicated to the development of novel antibiotics to combat drug-resistant bacterial infections, has closed a EUR22 million Series B investment round.
The round was led by new investor, Delos Capital. Existing investors Forbion Capital Partners, Edmond de Rothschild Investment Partners, EMBL Ventures and Allecra's co-Founder Nicholas Benedict also participated.
The proceeds will fund Phase 2 development of AAI202, Allecra's proprietary, novel antibiotic combination designed to treat drug-resistant Gram-negative bacterial infections. AAI202 is a combination of a powerful β-lactam antibiotic together with a proprietary, novel Extended Spectrum β-Lactamase Inhibitor. The combination is designed for use as
The Overseas Private Investment Corporation (OPIC), the US government’s development finance institution, has commenced the initial disbursement of a USD250 million loan to Apollo Towers Myanmar Limited, based in Yangon.
The disbursement marks OPIC’s first financing in the country as well as a historic milestone in public-private cooperation. Investors TPG Growth, Tillman Global Holdings, and Myanmar Investments International Limited facilitated the loan process and will continue to partner with Apollo on its expansion.
The development of towers by Apollo Towers Myanmar Limited (Apollo) has contributed to an increase in Myanmar’s mobile phone penetration rate from 5 percent to more
OM Asset Management (OMAM) is to acquire a 60 per cent equity interest in Landmark Partners, a secondary private equity, real estate and real asset investment firm.
Under the terms of the purchase agreement, OMAM will pay approximately USD240 million in cash at closing with the potential for an additional payment based on the growth of the business through 2018. The overall investment is expected to result in a purchase multiple of 8-10x Economic Net Income (ENI) generated by the Landmark transaction, prior to financing costs. OMAM intends to fund the closing payment using available capacity on its existing revolving
Hamilton Lane has held the final closing of Hamilton Lane Strategic Opportunities Fund 2016 with more than USD210 million in limited partner commitments, exceeding its initial target of USD150 million.
The Fund was created as a unique solution for LPs seeking short duration, risk-adjusted returns. Structured as an annual series with a single-year investment period, the Fund is focused on making credit-oriented investments with consistent cash yield.
"At Hamilton Lane, we are focused on using our global private markets platform to provide solutions to our clients," says Erik Hirsch, CIO of Hamilton Lane. "In a low-yield, public market environment, private
VFO, the company behind the Freedom Scientific and Optelec brands, has acquired Ai Squared, a developer of screen magnification and screen reading software.
Together, the companies offer the world’s broadest suite of assistive technology products for the visually-impaired. Each of the companies has a long history of providing innovative technology solutions that enable blind and low vision individuals to reach their full potential – to gain an education, obtain employment, succeed in professional careers, and live independently throughout their lives.
“Adding the brand, product portfolio and capabilities of Ai Squared to VFO gives us the broadest portfolio in the
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
